Le Lézard
Classified in: Health, Business
Subject: TRADE SHOWS/SEMINARS/WEBINARS

NobleCon14 - Noble Capital Markets' 14th Annual Institutional Investor Conference / Microcap Showcase; Diabetes Panel added


FORT LAUDERDALE BEACH, FL--(Marketwired - January 27, 2018) - Noble Capital Markets (Noble) announced today that it will host a comprehensive Diabetes Panel at 8:15am, January 30, 2018 at the W Hotel, Fort Lauderdale Beach, Florida. The elite panel will cover a broad spectrum of interests including the discovery and commercialization of new therapeutics and diagnostics, undervalued existing companies to watch, research, nutrition and awareness.

Included on the panel are Dr. Camillo Ricordi, director of the Diabetes Research Institute, Dr. Michael Castagna, CEO of MannKind Corporation, Eric Ende, Portfolio Manager of the NOBLE LifeSelect Fund, Diabetes Educator Lisa Siemens of Tandem Diabetes, Claudine De Niro, Beyond Type 1 Leadership Council and mother of a young daughter living with type 1 diabetes, and Scott Smith, CEO of Socrates Health Solutions. David Meltzer, former CEO of Leigh Steinberg Sports Agency, will act as moderator.

In addition to the panel, NOBLE will be joined by Stuart Bookatz, a cyclist who is embarking on a 3000 mile cross-country journey to benefit Beyond Type 1, a non-profit focused on education, advocacy, and a cure for Type 1 diabetes.

"It's the most comprehensive agenda we've put together since launching NobleCon fourteen years ago," said Mark Pinvidic, Noble's managing partner. "In addition to presentations from more than 130 C-suite executive teams, NobleCon14 features five panel presentations, two round table discussions, a 'rags-to-riches' keynote address and our signature evening networking event."

About NobleCon
NobleCon utilizes four tracks for companies to present to investors -- run simultaneously in half-hour intervals -- with total representation limited to 135 companies; a multi-sector blend of microcap emerging growth companies and more established small cap companies (market capitalization of $250 million - to $2 billion). One-on-one meetings between qualified investors and corporate executives are arranged and scheduled on behalf of participants. Panel presentations are open to all attendees. Comprehensive networking events are arranged for the evenings. Registration for investors is open to institutions, hedge fund managers, family offices, high-net-worth individuals, financial advisors, private equity and retail brokers.

About Noble Capital Markets
Noble Capital Markets established in 1984, is an equity-research driven, full-service, investment & merchant bank focused on the healthcare, media & entertainment, technology, natural resources and the transportation & logistics sectors. The company has offices in Boca Raton (HQ), New York, St. Louis and Boston. In addition to the annual multi-sector NobleCon, each year Noble hosts numerous "non-deal" corporate road shows and sector-specific conferences such as the Media, Finance & Investor Conference offered in partnership with the National Association of Broadcasters (NAB).

Members: FINRA, SIPC, MSRB www.noblecapitalmarkets.com


These press releases may also interest you

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...



News published on and distributed by: